Charles Piller December 18, 2015 Academic scientists who ignore legal requirements to publicly report clinical trial results often have received large payments from drug companies involved in the studies, a STAT review of federal data found. John Abramson (HMS) is quoted.Read the full article
Could Lithium Explain — and Treat — Alzheimer’s Disease? August 6, 2025 Study: Lithium loss ignites Alzheimer’s, but lithium compound can reverse disease in mice
AI Distinguishes Glioblastoma From Look-Alike Cancers During Surgery September 29, 2025 New tool helps surgeons tell apart aggressive glioblastoma from other cancers in the brain
Deaths Rose in Emergency Rooms After Hospitals Were Acquired by Private Equity Firms September 22, 2025 Staffing, salary cuts offer likely explanation for increase compared to non-private-equity hospitals
